06/03/2026
This past April, President Donald Trump made history when he announced that the United States would accelerate the approval process for certain safe psychedelic treatments like ibogaine and psilocybin for several disorders including Post-Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), Parkinson’s, and depression.
By: Rep. Rob Beiswenger, Idaho Freedom Caucus Member